# Principal Investigator Commitment Letters

**Protocol**: LAHAI-LI-2026-001
**Study**: Low-Dose Lithium Orotate Supplementation for Cognitive Protection
**Sponsor**: Lahai Health

---

## Instructions

Each PI should review their letter, complete the signature section, and return to Fabio Correa for IRB submission package assembly.

---

## Letter 1: Claudia Correa — Phase 1 Clinical Lead

**Date**: _______________

**To**: Sterling Institutional Review Board
**From**: Claudia Correa, Counselor
**Re**: Commitment Letter for Protocol LAHAI-LI-2026-001

I confirm my commitment to serve as **Phase 1 Clinical Lead** for the study titled "Low-Dose Lithium Orotate Supplementation for Cognitive Protection in Adults with Subjective Cognitive Decline."

### Responsibilities

As Phase 1 Clinical Lead, I commit to:

1. **Participant Recruitment**: Identify eligible participants from clinical practice and community outreach
2. **Informed Consent**: Conduct informed consent discussions and ensure participant understanding
3. **Clinical Assessment**: Administer cognitive assessments (MoCA, MMSE) at baseline and follow-up visits
4. **Participant Monitoring**: Maintain regular contact with participants for adherence and tolerability check-ins
5. **Adverse Event Reporting**: Document and report any adverse events according to protocol
6. **Protocol Compliance**: Ensure all study procedures are conducted according to IRB-approved protocol
7. **Documentation**: Maintain accurate study records and case report forms

### Time Commitment

I estimate dedicating approximately **4-6 hours per week** during active enrollment and **2-3 hours per week** during follow-up phases.

### Qualifications

I am a licensed counselor affiliated with Lahai Health with experience in cognitive health assessment and patient care. I have completed human subjects research training (CITI certification).

### Attestation

I have reviewed the study protocol and agree to conduct this research in compliance with:
- IRB-approved protocol and amendments
- Applicable federal, state, and local regulations
- Good Clinical Practice guidelines
- Lahai Health institutional policies

**Signature**: ________________________________

**Printed Name**: Claudia Correa

**Date**: _______________

**CITI Certification Date**: _______________

---

## Letter 2: Robert Deeble, PsyD — Research Oversight

**Date**: _______________

**To**: Sterling Institutional Review Board
**From**: Robert Deeble, PsyD, Practice Director
**Re**: Commitment Letter for Protocol LAHAI-LI-2026-001

I confirm my commitment to serve as **Research Oversight Lead** for the study titled "Low-Dose Lithium Orotate Supplementation for Cognitive Protection in Adults with Subjective Cognitive Decline."

### Responsibilities

As Research Oversight Lead, I commit to:

1. **Scientific Oversight**: Ensure the study is conducted with scientific rigor and methodological soundness
2. **Quality Assurance**: Review data quality and protocol adherence at regular intervals
3. **Team Supervision**: Provide guidance and mentorship to study staff
4. **Protocol Amendments**: Participate in decisions regarding protocol modifications
5. **Interim Analysis**: Review safety and feasibility data at pre-specified intervals
6. **Publication Review**: Contribute to manuscript preparation and ensure accurate reporting
7. **Institutional Liaison**: Serve as primary contact between Lahai Health and research regulatory bodies

### Time Commitment

I estimate dedicating approximately **2-4 hours per week** for oversight activities and team meetings.

### Qualifications

I am a licensed psychologist (PsyD) and Practice Director at Lahai Health with experience in clinical research methodology and cognitive assessment. I have completed human subjects research training (CITI certification).

### Attestation

I have reviewed the study protocol and agree to provide oversight in compliance with:
- IRB-approved protocol and amendments
- Applicable federal, state, and local regulations
- Good Clinical Practice guidelines
- Professional psychological practice standards

**Signature**: ________________________________

**Printed Name**: Robert Deeble, PsyD

**Date**: _______________

**CITI Certification Date**: _______________

---

## Letter 3: Phillip Cohen, MD — Medical Director

**Date**: _______________

**To**: Sterling Institutional Review Board
**From**: Phillip Cohen, MD
**Re**: Commitment Letter for Protocol LAHAI-LI-2026-001

I confirm my commitment to serve as **Medical Director** for the study titled "Low-Dose Lithium Orotate Supplementation for Cognitive Protection in Adults with Subjective Cognitive Decline."

### Responsibilities

As Medical Director, I commit to:

1. **Medical Eligibility Review**: Review participant medical history and laboratory results for eligibility determination
2. **Safety Monitoring**: Oversee safety assessments and medical adverse event evaluation
3. **Laboratory Oversight**: Review baseline and follow-up laboratory results (renal function, thyroid function, lithium levels)
4. **Medical Decision-Making**: Provide medical guidance for dose modifications, participant discontinuation, or referrals
5. **Serious Adverse Event Review**: Evaluate all serious adverse events for causality and reporting requirements
6. **Drug Interaction Review**: Assess potential medication interactions before participant enrollment
7. **Medical Emergency Protocol**: Serve as physician resource for any medical emergencies during study conduct

### Time Commitment

I estimate dedicating approximately **2-3 hours per week** during active enrollment for medical reviews, with additional time as needed for safety events.

### Qualifications

I am a licensed physician (MD) serving as Medical Director at Lahai Health. I have experience in clinical research and the medical management of patients on lithium therapy. I have completed human subjects research training (CITI certification).

### Attestation

I have reviewed the study protocol and agree to provide medical oversight in compliance with:
- IRB-approved protocol and amendments
- Applicable federal, state, and local regulations
- Good Clinical Practice guidelines
- Medical practice standards and licensure requirements

**Signature**: ________________________________

**Printed Name**: Phillip Cohen, MD

**Date**: _______________

**Medical License Number**: _______________

**CITI Certification Date**: _______________

---

## Assembly Checklist

| PI | Letter Signed | CITI Current | License Verified |
|----|---------------|--------------|------------------|
| Claudia Correa | ☐ | ☐ | ☐ |
| Robert Deeble, PsyD | ☐ | ☐ | ☐ |
| Phillip Cohen, MD | ☐ | ☐ | ☐ |

**All letters received by**: _______________

**IRB submission package assembled by**: Fabio Correa

---

*Document generated February 9, 2026 — Lahai Health Research Team*
